Target intelligence / Profile preview

Escherichia coli ATP synthase (F1Fo-ATP synthase) (F1Fo-ATP synthase)

Target
F1Fo-ATP synthase
Molecular classification
Enzyme, Transporter, F-type ATPase
01

Overview

Escherichia coli membrane-bound ATP synthase is a multi-subunit enzyme complex that synthesizes adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate, driven by the proton motive force across the inner membrane (Weber, 2006, Biochimica et Biophysica Acta). The enzyme consists of two functional domains: the membrane-embedded Fo sector, which facilitates proton translocation, and the cytoplasmic F1 sector, which contains the catalytic sites for ATP synthesis (Senior et al., 2002, Annual Review of Biophysics and Biomolecular Structure). In E. coli, this complex is essential for maintaining energy homeostasis, particularly during aerobic growth, and can also function in reverse to maintain a proton gradient during fermentation. As a therapeutic target, it is highly attractive for the development of novel antibiotics because its inhibition leads to the rapid depletion of cellular energy (Koul et al., 2007, Nature Reviews Microbiology). While it shares structural similarities with human mitochondrial ATP synthase, specific differences in the c-ring and other subunits allow for the design of selective inhibitors that minimize host toxicity (Ahmad et al., 2020, Frontiers in Microbiology). Various compounds, including diarylquinolines and natural polyphenols like resveratrol, have been identified as potent inhibitors of the bacterial enzyme (Hong-Geller et al., 2004, Journal of Biological Chemistry). Targeting this enzyme provides a mechanism to combat multi-drug resistant strains by disrupting a fundamental metabolic process.

Other names
F-type ATPaseF1Fo-ATPaseProton-translocating ATPaseH+-transporting ATP synthaseComplex VATP phosphohydrolase
02

Mechanism of action

Inhibition of the Fo domain proton channel or the F1 domain catalytic subunits to prevent ATP synthesis and proton translocation.

03

Biological functions

ATP synthesisProton transportEnergy metabolismOxidative phosphorylation
04

Disease associations

Infection
05

Safety considerations

Cross-reactivity with human mitochondrial ATP synthasePotential mitochondrial toxicityDevelopment of resistance via atp operon mutations
06

Interacting drugs

DCCD (N,N'-dicyclohexylcarbodiimide)

6 more in the full profile.

07

Biomarkers

Intracellular ATP concentrationProton motive force maintenanceBacterial growth inhibition

Beyond the preview

Go deeper on Escherichia coli ATP synthase (F1Fo-ATP synthase) (F1Fo-ATP synthase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli ATP synthase (F1Fo-ATP synthase) (F1Fo-ATP synthase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call